![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Allergan Releases Positive Data for Tear Stimulator
Allergan Releases Positive Data for Tear Stimulator
![](https://www.fdanews.com/ext/resources/test/Drug-Images2/eye-drug.gif?t=1433908164&width=430)
Allergan has released positive data from two pivotal trials evaluating its Oculeve intranasal tear neurostimulator, a handheld stimulator with disposable tips for the treatment of dry eye disease.
The device met its primary and secondary endpoints of increased tear production and the company is planning on a premarket submission for the device during the latter half of this year. — Anisa Jibrell
Upcoming Events
-
21Oct